Observational study of pneumonia patients in intensive care
Official title: A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
Run by Beijing Chao Yang Hospital · NCT02738645 · Data updated 2026-11-12
This study looks at patients with severe pneumonia in the intensive care unit to see how the illness affects them and what factors might influence their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Beijing Chao Yang Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | June 2016 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT02738645 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients admitted to the RICU with pneumonia and an anticipated hospital stay of more than 72 hours.
✕Probably not a fit
Patients admitted for reasons other than pneumonia or those with a shorter anticipated hospital stay will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study focuses on patients with pneumonia admitted to the Respiratory Intensive Care Unit (RICU). It aims to analyze clinical data to understand the epidemiology, morbidity, mortality, risk factors, clinical symptoms, and radiographic changes associated with severe pneumonia. By collecting and evaluating this information, the study seeks to improve clinical management and outcomes for patients suffering from severe pneumonia. The findings could provide valuable insights into the changing landscape of pneumonia caused by various respiratory viruses.
Why it matters
Potential benefit: If successful, this study could enhance the clinical management of severe pneumonia, leading to better patient outcomes.
How similar studies have gone: While similar studies have been conducted, this specific cohort study aims to address the evolving epidemiology of pneumonia in the context of new respiratory viruses, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * admit in RICU because of pneumonia of any causes * anticipated length of hospital stay more than 72h Exclusion Criteria: * admit in RICU because of other causes except pneumonia * do not agree to join this study * admit in RICU for the second time * anticipated length of hospital stay less than 72h
Where it's running
-
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Bing Sun, Dr — Beijing Chao-Yang Hospital, China
- Study coordinator: Bing Sun, Dr
- Email: ricusunbing@126.com
- Phone: 86013911151075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
-
Buteyko Breathing vs Incentive Spirometry for Smog-Induced Pneumonia
We’re testing whether the Buteyko Breathing Technique can improve oxygen levels and breathe easier for adults with smog-related pneumonia compared to incentive spirometry.
-
FUNGAL-P: A score to spot fungal pneumonia early in adults with pneumonia
Aimed at adults with pneumonia, this study tests a new score to help identify fungal pneumonia sooner so doctors can test appropriately and start antifungal treatment when needed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.